Steven Cohen Tyra Biosciences, Inc. Transaction History
Point72 Asset Management, L.P.
- $40.1 Billion
- Q1 2025
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 49,600 shares of TYRA stock, worth $445,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,600
Previous 12,783
288.02%
Holding current value
$445,904
Previous $177,000
160.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TYRA
# of Institutions
119Shares Held
55.6MCall Options Held
25KPut Options Held
5.4K-
Ra Capital Management, L.P. Boston, MA10.6MShares$95.6 Million2.05% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.14MShares$37.3 Million95.26% of portfolio
-
Alta Partners Management Company, L.P. Jackson, WY4.08MShares$36.7 Million90.83% of portfolio
-
Nextech Invest Ag4.06MShares$36.5 Million10.51% of portfolio
-
Nextech Invest, Ltd. Zurich, V84.06MShares$36.5 Million8.77% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $377M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...